000 01530 a2200421 4500
005 20250515174922.0
264 0 _c20090831
008 200908s 0 0 eng d
022 _a1537-6591
024 7 _a10.1086/600294
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAspinall, Sherrie L
245 0 0 _aSevere dysglycemia with the fluoroquinolones: a class effect?
_h[electronic resource]
260 _bClinical infectious diseases : an official publication of the Infectious Diseases Society of America
_cAug 2009
300 _a402-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAged
650 0 4 _aAnti-Bacterial Agents
_xadverse effects
650 0 4 _aBlood Glucose
_xdrug effects
650 0 4 _aCohort Studies
650 0 4 _aFemale
650 0 4 _aFluoroquinolones
_xadverse effects
650 0 4 _aHospitalization
650 0 4 _aHumans
650 0 4 _aHyperglycemia
_xchemically induced
650 0 4 _aHypoglycemia
_xchemically induced
650 0 4 _aIncidence
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRetrospective Studies
700 1 _aGood, Chester B
700 1 _aJiang, Rong
700 1 _aMcCarren, Madeline
700 1 _aDong, Diane
700 1 _aCunningham, Francesca E
773 0 _tClinical infectious diseases : an official publication of the Infectious Diseases Society of America
_gvol. 49
_gno. 3
_gp. 402-8
856 4 0 _uhttps://doi.org/10.1086/600294
_zAvailable from publisher's website
999 _c18963162
_d18963162